List of Tables
Table 1. Global Neurosurgery Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Neurosurgery Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Neurosurgery Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Neurosurgery Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Neurosurgery Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Neurosurgery Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Neurosurgery Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Neurosurgery Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Neurosurgery Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neurosurgery Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurosurgery Drug, Product Type & Application
Table 12. Global Key Manufacturers of Neurosurgery Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurosurgery Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurosurgery Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurosurgery Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Neurosurgery Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Neurosurgery Drug Sales Market Share by Region (2020-2025)
Table 19. Global Neurosurgery Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Neurosurgery Drug Sales Market Share by Region (2026-2031)
Table 21. Global Neurosurgery Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Neurosurgery Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Neurosurgery Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Neurosurgery Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Neurosurgery Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Neurosurgery Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Neurosurgery Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Neurosurgery Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Neurosurgery Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Neurosurgery Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Neurosurgery Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Neurosurgery Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Neurosurgery Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Neurosurgery Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Neurosurgery Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Neurosurgery Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Neurosurgery Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Neurosurgery Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Neurosurgery Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neurosurgery Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Neurosurgery Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Neurosurgery Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Neurosurgery Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Neurosurgery Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Neurosurgery Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Neurosurgery Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Neurosurgery Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Neurosurgery Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Neurosurgery Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Neurosurgery Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Neurosurgery Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Neurosurgery Drug Sales Market Share by Type (2020-2025)
Table 53. Global Neurosurgery Drug Sales Market Share by Type (2026-2031)
Table 54. Global Neurosurgery Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Neurosurgery Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Neurosurgery Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Neurosurgery Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Neurosurgery Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Neurosurgery Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Neurosurgery Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Neurosurgery Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Neurosurgery Drug Sales Market Share by Application (2020-2025)
Table 63. Global Neurosurgery Drug Sales Market Share by Application (2026-2031)
Table 64. Global Neurosurgery Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Neurosurgery Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Neurosurgery Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Neurosurgery Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Neurosurgery Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Neurosurgery Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Neurosurgery Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. AstraZeneca Neurosurgery Drug Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Biogen Company Information
Table 81. Biogen Description and Business Overview
Table 82. Biogen Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Biogen Neurosurgery Drug Product
Table 84. Biogen Recent Developments/Updates
Table 85. Jhonson & Jhonson Company Information
Table 86. Jhonson & Jhonson Description and Business Overview
Table 87. Jhonson & Jhonson Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Jhonson & Jhonson Neurosurgery Drug Product
Table 89. Jhonson & Jhonson Recent Developments/Updates
Table 90. ABBVIE Company Information
Table 91. ABBVIE Description and Business Overview
Table 92. ABBVIE Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. ABBVIE Neurosurgery Drug Product
Table 94. ABBVIE Recent Developments/Updates
Table 95. Takeda Pharmaceuticals Company Information
Table 96. Takeda Pharmaceuticals Description and Business Overview
Table 97. Takeda Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Takeda Pharmaceuticals Neurosurgery Drug Product
Table 99. Takeda Pharmaceuticals Recent Developments/Updates
Table 100. UCB Company Information
Table 101. UCB Description and Business Overview
Table 102. UCB Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. UCB Neurosurgery Drug Product
Table 104. UCB Recent Developments/Updates
Table 105. IPSEN Company Information
Table 106. IPSEN Description and Business Overview
Table 107. IPSEN Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. IPSEN Neurosurgery Drug Product
Table 109. IPSEN Recent Developments/Updates
Table 110. Standigm Company Information
Table 111. Standigm Description and Business Overview
Table 112. Standigm Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Standigm Neurosurgery Drug Product
Table 114. Standigm Recent Developments/Updates
Table 115. BlueStar Genomic Company Information
Table 116. BlueStar Genomic Description and Business Overview
Table 117. BlueStar Genomic Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. BlueStar Genomic Neurosurgery Drug Product
Table 119. BlueStar Genomic Recent Developments/Updates
Table 120. Tonix Pharmaceuticals Company Information
Table 121. Tonix Pharmaceuticals Description and Business Overview
Table 122. Tonix Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Tonix Pharmaceuticals Neurosurgery Drug Product
Table 124. Tonix Pharmaceuticals Recent Developments/Updates
Table 125. BlackThorn Therapeutics Company Information
Table 126. BlackThorn Therapeutics Description and Business Overview
Table 127. BlackThorn Therapeutics Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. BlackThorn Therapeutics Neurosurgery Drug Product
Table 129. BlackThorn Therapeutics Recent Developments/Updates
Table 130. Quentrix Company Information
Table 131. Quentrix Description and Business Overview
Table 132. Quentrix Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Quentrix Neurosurgery Drug Product
Table 134. Quentrix Recent Developments/Updates
Table 135. Wren Pharmaceuticals Company Information
Table 136. Wren Pharmaceuticals Description and Business Overview
Table 137. Wren Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Wren Pharmaceuticals Neurosurgery Drug Product
Table 139. Wren Pharmaceuticals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Neurosurgery Drug Distributors List
Table 143. Neurosurgery Drug Customers List
Table 144. Neurosurgery Drug Market Trends
Table 145. Neurosurgery Drug Market Drivers
Table 146. Neurosurgery Drug Market Challenges
Table 147. Neurosurgery Drug Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Neurosurgery Drug
Figure 2. Global Neurosurgery Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neurosurgery Drug Market Share by Type: 2024 & 2031
Figure 4. Tablets Product Picture
Figure 5. Solution Product Picture
Figure 6. Capsules Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neurosurgery Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Neurosurgery Drug Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Neurosurgery Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Neurosurgery Drug Market Size (2020-2031) & (US$ Million)
Figure 15. Global Neurosurgery Drug Sales (2020-2031) & (K Units)
Figure 16. Global Neurosurgery Drug Average Price (US$/Unit) & (2020-2031)
Figure 17. Neurosurgery Drug Report Years Considered
Figure 18. Neurosurgery Drug Sales Share by Manufacturers in 2024
Figure 19. Global Neurosurgery Drug Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Neurosurgery Drug Players: Market Share by Revenue in Neurosurgery Drug in 2024
Figure 21. Neurosurgery Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Neurosurgery Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Neurosurgery Drug Sales Market Share by Country (2020-2031)
Figure 24. North America Neurosurgery Drug Revenue Market Share by Country (2020-2031)
Figure 25. United States Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Neurosurgery Drug Sales Market Share by Country (2020-2031)
Figure 28. Europe Neurosurgery Drug Revenue Market Share by Country (2020-2031)
Figure 29. Germany Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Neurosurgery Drug Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Neurosurgery Drug Revenue Market Share by Region (2020-2031)
Figure 36. China Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Neurosurgery Drug Sales Market Share by Country (2020-2031)
Figure 46. Latin America Neurosurgery Drug Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Neurosurgery Drug Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Neurosurgery Drug Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Neurosurgery Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Neurosurgery Drug by Type (2020-2031)
Figure 56. Global Revenue Market Share of Neurosurgery Drug by Type (2020-2031)
Figure 57. Global Neurosurgery Drug Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Neurosurgery Drug by Application (2020-2031)
Figure 59. Global Revenue Market Share of Neurosurgery Drug by Application (2020-2031)
Figure 60. Global Neurosurgery Drug Price (US$/Unit) by Application (2020-2031)
Figure 61. Neurosurgery Drug Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
